Adams celebrates 10-year anniversary
CHESTER, N.J. Adams Respiratory Therapeutics Tuesday morning announced that it will commemorate the 10th anniversary of its incorporation with a celebration for employees on Sept. 12 at Municipal Field (Gazebo Park) in Chester, New Jersey.
“On the occasion of this important milestone, I applaud our employees, whose talents and tireless efforts have fueled Adams’ phenomenal growth in the past several years,” stated Michael Valentino, Adams president and chief executive officer. “I’m proud of our accomplishments and I look forward to a second decade of success with multiple new product introductions and our planned expansion into the prescription respiratory market.”
Adams, best known for its Mucinex and Delsym cough and cold products and the nationwide Mr. Mucus consumer advertising campaign, commenced operations in Fort Worth, Texas in September 1997. In April 2004, the company relocated its corporate headquarters from Fort Worth to Chester. Adams currently employees nearly 500 people and its Chester facility houses more than 80 of its employees. The company has expanded its headquarter operations twice since relocating to Chester in 2004 and doubled its portfolio of marketed respiratory products this year.
Federal, state and local officials are scheduled to attend and participate in a ceremony recognizing Adams for its decade of success as a specialty pharmaceutical company focused on the treatment of respiratory disorders.
“I congratulate Adams Respiratory Therapeutics on its 10-year anniversary, and the tremendous growth and success that this company has achieved in such a short period of time,” stated Stanley Kosierowski, chief operating officer and senior vice president, business support, New Jersey Economic Development Authority. “It is New Jersey’s good fortune to have companies like Adams come to our state, where they create jobs, become good neighbors and corporate citizens, and continue New Jersey’s fine tradition of improving public health by providing important medicines for the entire nation.”
In August 2007, Adams was named to Deloitte & Touche’s prestigious Technology Fast 50 Program for New Jersey, a ranking of the 50 fastest growing technology, media, telecommunications, and life sciences companies in the area. Adams was ranked No. 7 overall, based on achieving a revenue growth rate of 1,638 percent from 2002 to 2006.
Bodee recalls Zencore after FDA finds undeclared drugs in chemical analysis
CENTURY CITY, Calif. Bodee last month voluntarily recalled all of the company’s supplement product sold under the name Zencore Tabs after being informed by representatives of the Food and Drug Administration that lab analyses found the product contained potentially harmful, undeclared pharmaceutical ingredients.
FDA asserted that its chemical analysis revealed that one lot of Zencore Tabs contained aminotadalafil, an analog of tadalafil, the active ingredient in Eli Lilly’s Cialis erectile dysfunction medication.
FDA maintained that Aminotadalafil is close in structure to tadalafil and is expected to possess a similar pharmacological and adverse event profile. Further, FDA declared another lot of Zencore Tabs contained sildenafil, the active ingredient found in Pfizer’s Viagra, as well as sulfosildenafil and sulfohomosildenafil, both are analogs of sildenafil.
Zencore Tabs is sold in health food stores and by mail order nationwide and in Canada. The Zencore Tabs product is sold as a 2-capsule blister pack packaged in a retail booklet with five booklets in a box.
Customers who have this product in their possession should stop using it immediately and contact their physician if they have experienced any problems that may be related to taking this product.
Any adverse events that may be related to the use of this product should be reported to the FDA’s MedWatch Program by phone at 1-800-FDA-1088 or by fax at 1-800-FDA-0178 or by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787.
Vitamin Shoppe campaign to fight vitamin-A deficiency blindness
NORTH BERGEN, N.J. The Vitamin Shoppe announced Wednesday it will begin accepting cash donations on behalf of Vitamin Angels in support of that agency’s campaign, Operation 20/20, as part of the vitamin retailer’s 30th anniversary celebrations.
“With our Anniversary Sale in-store, in our catalog and on the web, we know our loyal customers will join us in supporting this important initiative to end childhood blindness caused by [vitamin-A deficiency],” stated Tony Truesdale, president and chief merchandising officer of The Vitamin Shoppe.
Vitamin Angels is committed to eliminating childhood blindness caused by vitamin-A deficiency by the year 2020. Operation 20/20 is the first major step in this global campaign, which launched this year in 15 countries.
The Vitamin Shoppe is raising funds for Vitamin Angels in store at the register. Customers can donate $1 or more to the campaign and sign a Vitamin Angels paper angel to hang in the store. Any customer who donates $5 or more will receive a special Operation 20/20 wristband as a thank you. Online customers can also donate with each purchase at www.vitaminshoppe.com.